IP Library Granted Patent US 9,303,092
Granted Patent B2
US 9,303,092 · App. 13/606,178 · Granted Apr 5, 2016

Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof

Inventors: Samuel M. Owens (Little Rock, AR); Frank Ivy Carroll (Durham, NC); Philip Abraham (Cary, NC)
Assignee: The Board of Trustees of the University of Arkansas
C07K16/44A61K31/13C07C217/60C07C233/18G01N33/946A61K31/137A61K2039/505C07B2200/07C07K2317/55Y10S436/823Y10S436/901Y10T436/173845
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,303,092
App. No.
13/606,178
Granted
Apr 5, 2016
Kind
B2
Abstract

The invention generally relates to hapten compounds comprising either (+) methamphetamine or (+) amphetamine conjugated to a linker. Generally speaking, hapten compounds of the invention may be used to elicit an immune response to one or more of (+) methamphetamine, (+) amphetamine, or (+) MDMA.

Claims (10)

1. A method for generating a monoclonal antibody or an antigen binding fragment thereof, the method comprising generating the monoclonal antibody or the antigen binding fragment thereof using an immunogen comprising a hapten conjugated to an immunogenic carrier, wherein said hapten has the structure

wherein said immunogenic carrier is conjugated to said hapten via the carboxylic group of the hapten, and

wherein:

R1 is selected from the group consisting of hydrogen and methyl; and

L is selected from the group consisting of O(CH 2 ) 5 attached to the benzene ring at the meta position, and O(CH 2 ) 9 attached to the benzene ring at the meta position, wherein indicates point of attachment to the benzene ring.

2. The method of claim 1 , wherein the immunogenic carrier is selected from the group consisting of KLH, ovalbumin, BSA, cationized BSA, thyroglobulin, a bacterial toxin and a bacterial toxoid.

3. The method of claim 1 , wherein L is O(CH 2 ) 9 .

4. The method of claim 1 , wherein L is O(CH 2 ) 5 .

5. The method of claim 1 , wherein L is O(CH 2 ) 9 attached to the benzene ring at the meta position and R 1 is methyl.

6. The method of claim 1 , wherein L is O(CH 2 ) 5 attached to the benzene ring at the meta position and R 1 is methyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 047667/0515 →
CONFIRMATORY LICENSE Recorded Nov 9, 2012
From: UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029275/0647 →
Continuity (6)
Division 12611708 · Nov 3, 2009
Division 11733085 · Apr 9, 2007
Continuation In Part 10255462 · Sep 26, 2002
Continuation In Part 09839549 · Apr 20, 2001
Provisional Application 60198902 · Apr 20, 2000
Related Publication 20130296537A1 · Nov 7, 2013